1 min readfrom TechCrunch

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Want to read more?

Check out the full article on the original site

View original article

Tagged with

#AI
#Artificial Intelligence
#Drug Discovery
#Life Sciences
#Startup
#Funding
#Investors
#Breakthroughs
#OpenAI
#Miles Wang
#Valuation
#Research
#Pharmaceuticals
#Biotechnology
#Machine Learning
#Computational Biology
#Data Science
#Algorithms
#Healthcare
#Innovation